← ANALYST RATINGS · TIPRANKS
Thermo Fisher (TMO): analyst forecast and price target
Price targets and ratings of
Analyst consensus
Strong Buy11 Buy3 Hold0 Sell
Ratings of 14 analysts in the last 3 months · top analysts only12-month forecast
$678−1.7% downside
Based on 14 price targets given in the last 3 months, the average target is $678, the highest $760, the lowest $575. The average is −1.7% from the last price of $690.
Highest target $760
Average target $678
Lowest target $575
Analyst ratings 34
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $756 → $794+5.0% | Buy | +15.1% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $739 → $777+5.1% | Buy | +12.6% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $749 → $787+5.1% | Buy | +14.1% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $700 → $735+5.0% | Hold | +6.5% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $743 → $780+5.0% | Buy | +13.0% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $759 → $797+5.0% | Buy | +15.5% | Reiterated | 17.10.26on TipRanks Oct 16 23:05 | — | |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $690 → $760+10.1% | Buy | +10.1% | Reiterated | 16.10.26on TipRanks Oct 17 08:15 | +0.2% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $750 → $756+0.8% | Buy | +9.6% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $734 → $739+0.7% | Buy | +7.1% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $744 → $749+0.7% | Buy | +8.6% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $694 → $700+0.9% | Hold | +1.4% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $737 → $743+0.8% | Buy | +7.7% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $753 → $759+0.8% | Buy | +10.0% | Reiterated | 15.10.26on TipRanks Oct 14 23:05 | — | |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $675 → $760+12.6% | Buy | +10.1% | Reiterated | 13.10.26on TipRanks 08:41 | +0.1%next day +2.6% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $743 → $750+0.9% | Buy | +8.7% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $727 → $734+1.0% | Buy | +6.4% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $737 → $744+0.9% | Buy | +7.8% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $688 → $694+0.9% | Hold | +0.6% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $730 → $737+1.0% | Buy | +6.8% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $747 → $753+0.8% | Buy | +9.1% | Reiterated | 13.10.26on TipRanks Oct 12 23:05 | — | |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $650 → $730+12.3% | Buy | +5.8% | Assigned | 12.10.26on TipRanks 09:00 | +0.7%next day +0.1% | ↗ |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $575 | Hold | −16.7% | Reiterated | 12.10.26on TipRanks 06:30 | +0.7%next day +0.1% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $755 → $743−1.6% | Buy | +7.7% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $738 → $727−1.5% | Buy | +5.4% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $748 → $737−1.5% | Buy | +6.8% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $698 → $688−1.4% | Hold | −0.3% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $742 → $730−1.6% | Buy | +5.8% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $758 → $747−1.5% | Buy | +8.3% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $650 → $745+14.6% | Buy | +8.0% | Reiterated | 09.10.26on TipRanks 08:10 | +0.3%next day +0.7% · 5 days +6.8% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $772 → $755−2.2% | Buy | +9.4% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $755 → $738−2.3% | Buy | +7.0% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $765 → $748−2.2% | Buy | +8.4% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $714 → $698−2.2% | Hold | +1.2% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $758 → $742−2.1% | Buy | +7.5% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $775 → $758−2.2% | Buy | +9.9% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $650 → $750+15.4% | Buy | +8.7% | Reiterated | 07.10.26on TipRanks 03:55 | +1.1%next day −1.1% · 5 days +2.7% | ↗ |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $746 → $772+3.5% | Buy | +11.9% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $730 → $755+3.4% | Buy | +9.4% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $740 → $765+3.4% | Buy | +10.9% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $691 → $714+3.3% | Hold | +3.5% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $733 → $758+3.4% | Buy | +9.9% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $750 → $775+3.3% | Buy | +12.3% | Reiterated | 07.10.26on TipRanks Oct 6 23:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $744 → $746+0.3% | Buy | +8.1% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $728 → $730+0.3% | Buy | +5.8% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $737 → $740+0.4% | Buy | +7.2% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $688 → $691+0.4% | Hold | +0.1% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $731 → $733+0.3% | Buy | +6.2% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $747 → $750+0.4% | Buy | +8.7% | Reiterated | 05.10.26on TipRanks Oct 4 23:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $775 → $744−4.0% | Buy | +7.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $758 → $728−4.0% | Buy | +5.5% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $768 → $737−4.0% | Buy | +6.8% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $717 → $688−4.0% | Hold | −0.3% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $761 → $731−3.9% | Buy | +5.9% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $778 → $747−4.0% | Buy | +8.3% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $770 → $775+0.6% | Buy | +12.3% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $753 → $758+0.7% | Buy | +9.9% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $763 → $768+0.7% | Buy | +11.3% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $712 → $717+0.7% | Hold | +3.9% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $756 → $761+0.7% | Buy | +10.3% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $773 → $778+0.6% | Buy | +12.8% | Reiterated | 01.10.26on TipRanks Sep 30 23:05 | — | |
| Eve Burstein★★★★★★★★★★#1300 · hits 72% · avg +25.0% | Bernstein | $575 | Hold | −16.7% | Reiterated | 25.09.26on TipRanks Sep 26 08:40 | −1.0%next day +1.3% · 5 days −2.8% | ↗ |
| Justin Bowers★★★★★★★★★★#8679 · hits 47% · avg 0.0% | Deutsche Bank | $635 → $720+13.4% | Buy | +4.3% | Reiterated | 25.09.26on TipRanks 08:35 | −1.0%next day +1.3% · 5 days −2.8% | ↗ |
| Unknown Analyst | Goldman Sachs | $650 → $780+20.0% | Buy | +13.0% | Reiterated | 20.09.26on TipRanks Sep 23 00:05 | −0.4%next day 0.0% · 5 days +4.0% | ↗ |
| Daniel Arias★★★★★★★★★★#1848 · hits 50% · avg +8.0% | Stifel Nicolaus | — | Buy | — | Reiterated | 15.09.26on TipRanks Sep 16 08:05 | +5.1%next day +1.5% · 5 days +0.3% | ↗ |
| Doug Schenkel★★★★★★★★★★#216 · hits 65% · avg +26.2% | Wolfe Research | $540 → $730+35.2% | Buy | +5.8% | Initiated | 08.09.26on TipRanks Sep 9 06:15 | −1.2%next day +0.9% · 5 days +7.6% | ↗ |
| Michael Luo CFA★★★★★★★★★★#2730 · hits 49% · avg +11.8% | CLSA | $748 | Buy | +8.4% | Initiated | 03.09.26on TipRanks 05:55 | +0.6%next day −0.4% · 5 days −0.2% | ↗ |
| Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% | J.P. Morgan | $690 | Buy | 0.0% | Reiterated | 28.07.26on TipRanks Jul 29 08:18 | +2.8%next day +1.5% · 5 days −6.1% | ↗ |
| Aristotelis Moutopoulos★★★★★★★★★★#9693 · hits 56% · avg −1.5% | DZ BANK AG | $630 | Buy | −8.7% | Reiterated | 27.07.26on TipRanks Sep 10 03:00 | −1.6%next day +2.8% · 5 days +0.1% | |
| Jill Wu★★★★★★★★★★#513 · hits 52% · avg +26.4% | CMB International Securities | $620 → $660+6.5% | Buy | −4.3% | Reiterated | 27.07.26on TipRanks 14:08 | −1.6%next day +2.8% · 5 days +0.1% | ↗ |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $510 → $600+17.6% | Hold | −13.0% | Reiterated | 27.07.26on TipRanks 14:06 | −1.6%next day +2.8% · 5 days +0.1% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $620 → $650+4.8% | Buy | −5.8% | Reiterated | 24.07.26on TipRanks 16:07 | −1.6%next day +2.8% · 5 days +0.1% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $625 → $650+4.0% | Buy | −5.8% | Reiterated | 24.07.26on TipRanks 05:14 | −0.8%next day −1.6% · 5 days 0.0% | ↗ |
| Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% | William Blair | — | Buy | — | Reiterated | 24.07.26on TipRanks 05:14 | −0.8%next day −1.6% · 5 days 0.0% | ↗ |
| Dan Leonard★★★★★★★★★★#656 · hits 62% · avg +14.1% | RBC Capital | $490 → $580+18.4% | Hold | −15.9% | Reiterated | 23.07.26on TipRanks Jul 24 07:10 | +9.9%next day −0.8% · 5 days +0.3% | ↗ |
| Daniel Brennan★★★★★★★★★★#271 · hits 58% · avg +21.8% | TD Cowen | $625 → $675+8.0% | Buy | −2.2% | Reiterated | 23.07.26on TipRanks Jul 24 05:14 | +9.9%next day −0.8% · 5 days +0.3% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $630 → $650+3.2% | Buy | −5.8% | Reiterated | 23.07.26on TipRanks Jul 24 05:14 | +9.9%next day −0.8% · 5 days +0.3% | ↗ |
| Tycho Peterson★★★★★★★★★★#1097 · hits 57% · avg +9.8% | Jefferies | $650 → $630−3.1% | Buy | −8.7% | Reiterated | 23.07.26on TipRanks Jul 24 05:14 | +9.9%next day −0.8% · 5 days +0.3% | ↗ |
| Brandon Couillard★★★★★★★★★★#287 · hits 63% · avg +18.4% | Wells Fargo | $615 | Buy | −10.9% | Assigned | 23.07.26on TipRanks Jul 24 05:14 | +9.9%next day −0.8% · 5 days +0.3% | ↗ |
| Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% | Evercore ISI | $575 → $570−0.9% | Buy | −17.4% | Reiterated | 06.07.26on TipRanks 08:55 | −2.0%next day +0.3% · 5 days +2.4% | ↗ |
| Sidharth Sahoo★★★★★★★★★★#9090 · hits 43% · avg −0.9% | HSBC | $670 → $540−19.4% | Hold | −21.7% | Downgrade | 03.06.26on TipRanks 05:25 | −1.0%next day +1.3% · 5 days +5.5% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | $535 | Buy | −22.5% | Initiated | 01.06.26on TipRanks 16:50 | −2.6%next day −1.0% · 5 days +5.5% | ↗ |
| Hans Engel★★★★★★★★★★#1835 · hits 58% · avg +11.1% | Erste Group | — | Hold | — | Reiterated | 05.05.26on TipRanks 07:00 | +0.1%next day −0.1% · 5 days −3.6% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $610 → $560−8.2% | Buy | −18.8% | Reiterated | 30.04.26on TipRanks May 4 08:55 | +1.7%next day −2.3% · 5 days −2.7% | ↗ |
| Catherine Ramsey Schulte★★★★★★★★★★#864 · hits 53% · avg +11.2% | Robert W. Baird | $653 → $639−2.1% | Buy | −7.4% | Reiterated | 24.04.26on TipRanks 06:40 | −0.1%next day −0.5% · 5 days −1.0% | ↗ |
| Natalya Davies★★★★★★★★★★#4625 · hits 89% · avg +16.4% | Rothschild & Co Redburn | $620 | Buy | −10.1% | Reiterated | 17.04.26on TipRanks 08:35 | +0.8%next day +0.1% · 5 days −11.3% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $685 | Buy | −0.7% | Reiterated | 06.04.26on TipRanks Apr 7 06:20 | −1.1%next day +0.2% · 5 days +1.2% | ↗ |
| Paul Knight★★★★★★★★★★#4215 · hits 45% · avg +3.5% | KeyBanc | $750 | Buy | +8.7% | Upgrade | 08.12.25on TipRanks Dec 7 19:10 | −0.5%next day −0.8% · 5 days +1.9% | ↗ |
| Puneet Souda★★★★★★★★★★#2942 · hits 45% · avg +4.1% | Leerink Partners | $545 → $580+6.4% | Buy | −15.9% | Reiterated | 23.10.25on TipRanks Oct 22 14:50 | +2.2%next day +0.2% · 5 days −4.5% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Thermo Fisher
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $656 at a price of $675 (−2.8%); now: $688 at $690 (−0.2%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 27 | 30 | 27 | 19 | 17 | 8 |
| Hold | 3 | 5 | 7 | 5 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 21.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $6.40 (from $6.33 to $6.47). Last quarter: $6.03.
Sales
Next quarter’s sales estimate — $12.0B (from $11.8B to $12.1B). Last quarter: $12.0B.
Best top-analyst consensus in the sector · Healthcare
About Thermo Fisher
- CEO: Marc N. Casper
- Employees: 125,000
- 168 Third Avenue, Waltham, MA, 02451, US
- www.thermofisher.com
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research
Data from the stock’s TipRanks forecast page, read 46 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗